Literature DB >> 17325912

Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.

Michiko Yamagata, Toshimitsu Murohisa, Kohei Tsuchida, Yutaka Okamoto, Saburo Tsunoda, Masae Nakamura, Koji Kusano, Yuichi Majima, Toru Kuniyoshi, Makoto Iijima, Hitoshi Sugaya, Hideyuki Hiraishi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17325912     DOI： 10.1080/10428190601059704

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

Review 1.  The management of chronic hepatitis B in Asian Americans.

Authors:  Myron J Tong; Calvin Q Pan; Hie-Won Hann; Kris V Kowdley; Steven-Huy B Han; Albert D Min; Truong-Sinh Leduc
Journal:  Dig Dis Sci       Date:  2011-09-21       Impact factor: 3.199

Review 2.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

3.  A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin's lymphoma patient.

Authors:  Chunchen Wu; Hui Shi; Mengji Lu; Yang Xu; Xinwen Chen
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

4.  Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?

Authors:  Jinoos Yazdany; Leonard Calabrese
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

Review 5.  Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.

Authors:  Man Fai Law; Rita Ho; Carmen K M Cheung; Lydia H P Tam; Karen Ma; Kent C Y So; Bonaventure Ip; Jacqueline So; Jennifer Lai; Joyce Ng; Tommy H C Tam
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

6.  Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy.

Authors:  Eui Bae Kim; Dae Sik Kim; Seh Jong Park; Yong Park; Kyoung Ho Rho; Seok Jin Kim
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

7.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

Review 8.  Reactivation of hepatitis B virus infection in patients with hematologic disorders.

Authors:  Bo Wang; Ghulam Mufti; Kosh Agarwal
Journal:  Haematologica       Date:  2019-02-07       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.